Has the time come to end use of the blue inhaler?
- PMID: 33932346
- DOI: 10.1016/S2213-2600(21)00185-5
Has the time come to end use of the blue inhaler?
Conflict of interest statement
SRD reports grants from Cure Kids and the Health Research Council of New Zealand, outside of the submitted work. CAB reports grants from Cure Kids, the Health Research Council of New Zealand, the Australian National Health and Medical Research Council, and FluLab, outside of the submitted work. RB reports grants and personal fees from AstraZeneca and the Health Research Council of New Zealand, grants from Cure Kids and Genentech, and personal fees from Avillion and Cipla, outside of the submitted work. RB is Chair of the Asthma and Respiratory Foundation of New Zealand adolescent and adult asthma guidelines 2020. AB and LH declare no competing interests.
Comment on
-
Treatment of mild-to-moderate asthma in childhood and adolescence in 2021.Lancet Respir Med. 2021 May;9(5):443-445. doi: 10.1016/S2213-2600(21)00135-1. Epub 2021 Mar 12. Lancet Respir Med. 2021. PMID: 33721559 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
